C41H41Cl2N7O3 — CID 174110005
(3R)-3-chloro-10-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-4-methyl-2-[1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)indol-3-yl]-6-(1,3,5-trimethylpyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-1-one (PubChem CID 174110005) has the molecular formula C41H41Cl2N7O3 and a molecular weight of 750.73 g/mol. Its IUPAC name is (3R)-3-chloro-10-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-4-methyl-2-[1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)indol-3-yl]-6-(1,3,5-trimethylpyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-1-one.
| Compound Name | (3R)-3-chloro-10-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-4-methyl-2-[1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)indol-3-yl]-6-(1,3,5-trimethylpyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-1-one |
|---|---|
| PubChem CID | 174110005 |
| Molecular Formula | C41H41Cl2N7O3 |
| Molecular Weight | 750.73 g/mol |
| Exact Mass | 749.26 |
| IUPAC Name | (3R)-3-chloro-10-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-4-methyl-2-[1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)indol-3-yl]-6-(1,3,5-trimethylpyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-1-one |
| SMILES | Cc1noc(-c2ccc3c(c2)c(N2C(=O)c4c(CCCOc5cc(C)c(Cl)c(C)c5)c5cccc(-c6c(C)nn(C)c6C)c5n4C(C)[C@H]2Cl)cn3C)n1 |
| InChI | InChI=1S/C41H41Cl2N7O3/c1-21-17-28(18-22(2)36(21)42)52-16-10-13-30-29-11-9-12-31(35-23(3)45-48(8)24(35)4)37(29)49-25(5)39(43)50(41(51)38(30)49)34-20-47(7)33-15-14-27(19-32(33)34)40-44-26(6)46-53-40/h9,11-12,14-15,17-20,25,39H,10,13,16H2,1-8H3/t25?,39-/m0/s1 |
| InChIKey | GPVVZCZFPQKZQO-HNAGTWBMSA-N |
| XLogP | 9.58 |
| TPSA | 96.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 53 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 750.73 |
| LogP ≤ 5 | 9.58 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'} |
|---|